13F Data
Security · CUSIP 24344T101

DECIPHERA PHARMACEUTICALS IN

COM · institutional ownership from 13F filings
13F holders
0
Shares held
0
Value held
$0
New / sold out
0 / 1
Added / reduced
0 / 0
net -50.0K shares

13F holders by quarter

Q3 2017: 49Q4 2017: 59Q1 2018: 55Q2 2018: 89Q3 2018: 89Q4 2018: 79Q1 2019: 81Q2 2019: 86Q3 2019: 124Q4 2019: 155Q1 2020: 150Q2 2020: 170Q3 2020: 163Q4 2020: 185Q1 2021: 170Q2 2021: 150Q3 2021: 164Q4 2021: 141Q1 2022: 124Q2 2022: 129Q3 2022: 151Q4 2022: 144Q1 2023: 147Q2 2023: 146Q3 2023: 158Q4 2023: 165Q1 2024: 178Q2 2024: 1Q3 2024: 0
Q3 2017Q3 2024

Net shares bought by existing holders

Q3 2017: 14.4MQ4 2017: 1.3MQ1 2018: -92.5KQ2 2018: 5.1MQ3 2018: 634.7KQ4 2018: 667.4KQ1 2019: 487.7KQ2 2019: 754.0KQ3 2019: 12.6MQ4 2019: -243.2KQ1 2020: 4.8MQ2 2020: 2.1MQ3 2020: -228.9KQ4 2020: 721.6KQ1 2021: -311.9KQ2 2021: 115.2KQ3 2021: -759.4KQ4 2021: 3.6MQ1 2022: -2.8MQ2 2022: 4.7MQ3 2022: 1.0MQ4 2022: 19.6KQ1 2023: 5.8MQ2 2023: -1.7MQ3 2023: 45.4KQ4 2023: 3.8MQ1 2024: 2.8MQ2 2024: -63.0MQ3 2024: -50.0K
Q3 2017Q3 2024

Top holders · Q3 2024

Nothing to show.

Biggest buyers

Nothing to show.

Biggest sellers

ManagerChangeShares changeChange %
DekaBank Deutsche GirozentraleSold out-50,000-100.0%